Clinical Trial Update: Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients

View source ↗

Summary

This clinical trial update reports safety findings for ticagrelor in Chinese patients with Acute Coronary Syndrome. The study NCT02430493 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome (ACS) | Status: COMPLETED